MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0030203
Orange Medipharmaceuticals Private Limited - pharma in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹74.37 Lakh
▼ 42% YoY
Net profit · FY 2024
₹7,298
Net margin 0.1%
EBITDA · FY 2024
₹66,772
EBITDA margin 0.9%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹22.44 Lakh
Issued & subscribed
Open charges
₹40 Lakh
Secured borrowings
Company age
11 yrs
Est. 2015
Directors on board
3
As per MCA filings
About Orange Medipharmaceuticals Private Limited
Data last updated:
Orange Medipharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 November 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24233UP2015PTC074326. Its GSTIN is 09AACCO3688D1ZA (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹22.44 Lakh. It is led by directors including Imran Ahmad Ansari and Humera Yaseen.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 631/168 – A Rajeev Nagar Ismail Ganj Ward – II, Lucknow, Uttar Pradesh, India – 226016.
As per the financials filed for FY 2024, the company reported a revenue of ₹74.37 Lakh, a decline of 42% compared to the previous year. For the same year it recorded a net profit of ₹7,298 (net margin 0.1%) and EBITDA of ₹66,772 (EBITDA margin 0.9%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 19% over five years.
As per MCA filings, the company has open charges of ₹40 Lakh on record.
Orange Medipharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0030203). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website orangemedipharma.com.
Company details
CIN U24233UP2015PTC074326
Registration Number 074326
Incorporation Date 05 November 2015
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-50-0030203
Key People
Imran Ahmad Ansari Director Humera Yaseen Director Abdullah Saleh Salmen Anooz Al Ameri Director Recognitions & Rankings of Orange Medipharmaceuticals
Contact details
Orange Medipharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its website is orangemedipharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No. 631/168 – A Rajeev Nagar Ismail Ganj Ward – II, Lucknow, Uttar Pradesh, India – 226016
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Orange Medipharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Orange Medipharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Orange Medipharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Orange Medipharmaceuticals Private Limited, buy the company report.
Financials of Orange Medipharmaceuticals Private Limited
FY 2025 filings availableOrange Medipharmaceuticals Private Limited reported revenue of ₹74.37 Lakh (down 42% YoY) for FY 2024.
Revenue · FY 2024
₹74.37 Lakh ▼ 42%
Net profit · FY 2024
₹7,298 margin 0.1%
EBITDA · FY 2024
₹66,772 margin 0.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 42%
3 years · compounded
▼ 10%
5 years · compounded
▼ 19%
EBITDA CAGR growth
1 year
▼ 84%
3 years · compounded
▼ 31%
5 years · compounded
▼ 55%
Revenue has declined at a compounded annual rate (CAGR) of 19% over five years, including a 42% fall in the latest year. EBITDA fell 84% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹66,772 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7,298 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Orange Medipharmaceuticals Private Limited, buy the company report.
Board of directors of Orange Medipharmaceuticals Private Limited
Orange Medipharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Imran Ahmad Ansari | Director | 05 Nov 2015 | 10 Years 11 Months | Current |
| Humera Yaseen | Director | 05 Nov 2015 | 10 Years 11 Months | Current |
| Abdullah Saleh Salmen Anooz Al Ameri | Director | 17 May 2017 | 9 Years 5 Months | Current |
Peer comparison
Orange Medipharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dr. LBR Medi Care & Research Private Limited | ₹74.6 Lakh (FY 2025) | -17.0% | Chandigarh, India | |||
| Morris Pharmaceuticals Private Limited | ₹74.58 Lakh (FY 2024) | 20.0% | Varanasi, Uttar Pradesh, India | |||
| Orange Medipharmaceuticals Private Limitedthis company | ₹74.37 Lakh (FY 2024) | ₹7,298 | 0.1% | -42.0% | Lucknow, Uttar Pradesh, India | |
| Alleviate Lifescience Private Limited | ₹74.22 Lakh (FY 2025) | -36.0% | Guwahati, Assam, India | |||
| Medi Trade India Pvt Ltd | ₹73.89 Lakh (FY 2025) | 1.0% | Guwahati, Assam, India |
To see the full peer comparison of Orange Medipharmaceuticals Private Limited, buy the company report.
Auditor
Orange Medipharmaceuticals Private Limited is audited by SANJAY GYANESH & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJAY GYANESH & CO | FY 2020 | 007251C |
Shareholding
The shareholding of Orange Medipharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Orange Medipharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹40 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Jun 2021 | 100455254 | Others | ₹40 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Orange Medipharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Orange Medipharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Orange Medipharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCO3688D1ZA | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Orange Medipharmaceuticals Private Limited, buy the company report.
Recent activity
Orange Medipharmaceuticals Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Abdullah Saleh Salmen Anooz Al Ameri ceased to be Additional Director on 29 Sep 2017.
AGM
Orange Medipharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Orange Medipharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Charges
A charge with Others amounted to Rs. 40.00 Lakh with Charge ID 100455254 was registered on 23 Jun 2021.
Ceased
Abdullah Saleh Salmen Anooz Al Ameri ceased to be Additional Director.
Appointed
Abdullah Saleh Salmen Anooz Al Ameri was appointed as Director.
Appointed
Humera Yaseen was appointed as Director.
Appointed
Imran Ahmad Ansari was appointed as Director.
Incorporation
05 Nov 2015
Orange Medipharmaceuticals Private Limited was registered on 05 Nov 2015 with Roc Uttar Pradesh I & aged 10 years 11 months as per MCA records.
Frequently asked questions
Orange Medipharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 November 2015 (11+ years old) and is registered under CIN U24233UP2015PTC074326.
Orange Medipharmaceuticals has 3 current directors:
- Imran Ahmad Ansari - Director
- Humera Yaseen - Director
- Abdullah Saleh Salmen Anooz Al Ameri - Director
The latest financial statements of Orange Medipharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Orange Medipharmaceuticals is 09AACCO3688D1ZA, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Orange Medipharmaceuticals is U24233UP2015PTC074326. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Orange Medipharmaceuticals was incorporated on 05 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Orange Medipharmaceuticals by revenue are Dr. LBR Medi Care & Research Private Limited, Morris Pharmaceuticals Private Limited, Alleviate Lifescience Private Limited, Medi Trade India Pvt Ltd, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Abdullah Saleh Salmen Anooz Al Ameri ceased to be Additional Director on 29 Sep 2017. Abdullah Saleh Salmen Anooz Al Ameri was appointed as Director on 17 May 2017. Humera Yaseen was appointed as Director on 05 Nov 2015. Orange Medipharmaceuticals has 4 board changes on record in total.
Yes, Orange Medipharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0030203).
Orange Medipharmaceuticals can be reached through the website orangemedipharma.com. Its registered office is in Lucknow, Uttar Pradesh, India.
The registered office of Orange Medipharmaceuticals is at H.No. 631168 – A Rajeev Nagar Ismail Ganj Ward – II, Lucknow, Uttar Pradesh, India – 226016.